publication date: Dec. 21, 2010

In this issue: 

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely;

Gleevec Approved For Pediatric CML;

Peter Boyle Elected IARC Director;

Blackburn Wins BMS Award;

ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations;

Funding Opportunities (8-page issue).

Download (PDF 196KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.